10-K Decoder · All companies

Edgewise Therapeutics, Inc.

EWTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$191M−$159M−20.5%
Net income−$168M−$134M−25.4%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$46.1M−$46.9M+1.7%
Net income$1.17B−$40.7M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Edgewise's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Edgewise profitable in FY2025?
No: net income was −$168M and operating income −$191M in FY2025.
What was Edgewise's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.